Search
60 Degrees Pharmaceuticals Inc
SXTPAdd to Watchlist
0.930USD
0.0000.00%
Market hours 09/10, 15:48（ET）
2.54MMarket Cap
LossP/E TTM
60 Degrees Pharmaceuticals Inc (SXTP) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to 60 Degrees Pharmaceuticals Inc in the past month.
Buy
0 Strong Buy
1 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
3.700USD+302.48%
SXTP Analyst Recommendation Trends
In the current month, SXTP has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SXTP average Analyst price target in the last month is 3.700.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
2
2
2
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
SXTP Analyst Rating for Peer Comparison
Updated: Sep 10, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
AbbVie Inc
ABBV
7
19
6
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Bristol-Myers Squibb Co
BMY
5
6
18
2
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, SXTP EPS is projected to reach -0.745 in FY2026Q3, following reported EPS of -0.904 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-2.28
-0.76
-0.68
-0.74
-0.86
Actual
-1.47
-1.28
-0.90
--
--
Surprise
+35.56%
-68.84%
-32.93%
--
--
FAQs
What is 60 Degrees Pharmaceuticals Inc's expected revenue for the next quarter?
60 Degrees Pharmaceuticals Inc's expected revenue is 300.00K.
What is 60 Degrees Pharmaceuticals Inc's price target?
Analysts forecast that 60 Degrees Pharmaceuticals Inc's price target is USD 3.70, with the highest forecast at USD 3.70 and the lowest forecast at USD 3.70.
How have 60 Degrees Pharmaceuticals IncSXTP's recent earnings per share performed?
The market expectation was USD -0.90, while 60 Degrees Pharmaceuticals IncSXTP's earnings per share (EPS) for the previous quarter was USD -1.28. EPS for the next quarter is expected at USD -0.74.
What is the analyst rating for 60 Degrees Pharmaceuticals Inc?
Based on the ratings of 60 Degrees Pharmaceuticals Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.